Comparison of the Epic CTC HRD assay vs. tumor DDR mutations in metastatic castration-resistant prostate cancer (mCRPC) patients (pts)

被引：0
|
作者：
Schonhoft, Joseph [1 ]
Jendrisak, Adam [1 ]
Lee, Jerry [1 ]
Rodriguez, Angel [1 ]
Sutton, Ramsay [1 ]
Wang, Yipeng [1 ]
Dittamore, Ryan [1 ]
Landers, Mark [1 ]
机构：
[1] Epic Sci, San Diego, CA USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-2228
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2228
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Evaluation of clinical phenotype, survival, and circulating tumor cell (CTC) enumeration in men with metastatic castration-resistant prostate cancer (mCRPC).
    Bitting, Rhonda Lynn
    Healy, Patrick
    Halabi, Susan
    George, Daniel J.
    Ko, Jung Hyun
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] Circulating tumor cell (CTC) genomic signatures of hormone therapy resistance in men with metastatic castration-resistant prostate cancer (mCRPC)
    Gupta, Santosh
    Halabi, Susan
    Kemeny, Gabor
    Anand, Monika
    Nanus, David M.
    Giannakakou, Paraskevi
    George, Daniel J.
    Gregory, Simon
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [23] Molecular characterization of circulating tumor cells (CTC) and CTC subpopulations in progressive metastatic castration resistant prostate cancer (mCRPC).
    Dittamore, Ryan
    Louw, Jessica
    Krupa, Rachel
    Anand, Aseem
    Danila, Daniel Costin
    Arslan, Zaina
    Bales, Natalee
    Marrinucci, Dena
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [24] Real-world analysis of patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving vs not receiving chemotherapy in the treatment sequence
    Morgans, A. K.
    Divan, H. A.
    Birtle, A. J.
    Dorff, T.
    Ozatilgan, A.
    Graff, J. N.
    ANNALS OF ONCOLOGY, 2019, 30 : 334 - 334
  • [25] ENCORE: A phase 2 trial of enfortumab vedotin (EV) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
    Swami, Umang
    Faust, Caitlin
    Leonhart, Samuel
    Haaland, Benjamin
    Jones, Kristen
    Li, Haoran
    Sahu, Kamal Kant Kant
    Thomas, Vinay Mathew
    Phunrab, Tenzin Kunsang
    Batten, Julia
    Maxwell, Lindsay
    Lloyd, Jennifer
    Kohli, Manish
    Gupta, Sumati
    Thorne, Kelli
    Maughan, Benjamin L.
    Agarwal, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [26] Treatment sequence in elderly metastatic castration-resistant prostate cancer (mCRPC) patients (pts) in a prospective cohort study.
    Jose Mendez-Vidal, Maria
    Lozano, Rebeca
    Castro, Elena
    Romero-Laorden, Nuria
    Rodriguez-Vida, Alejo
    Lainez, Nuria
    Hernandez, Amaia
    Villatoro, Rosa
    Zambrana, Francisco
    Villa Guzman, Jose Carlos
    Garcia Dominguez, Rocio
    Galvan Ruiz, Saray
    Escribano, Ricardo
    Gallardo Diaz, Enrique
    Querol, Rosa
    Luque, Raquel
    Gonzalez del Alba, Aranzazu
    Puente, Javier
    Olmos, David
    Lorente, David
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] Real-world treatment (Tx) patterns of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) in the US
    Shore, N.
    Laliberte, F.
    Ionescu-Ittu, R.
    Gayle, A.
    Amin, S.
    Yang, L.
    Payne, S.
    Mahendran, M.
    Lejeune, D.
    Yu, L.
    Burgents, J.
    Duh, M. S.
    Ghate, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S534 - S535
  • [28] Sequencing of chemotherapy and androgen-axis inhibitors (AAIs) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
    Dhawan, Ravinder
    Yang, Tony
    Miao, Raymond
    Hennessy, Daniel
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [29] Use of PSMA PET in metastatic castration-resistant prostate cancer (mCRPC)
    Jensen, A.
    Karunaratna, N.
    Wong, S.
    Shapiro, J.
    Weickhardt, A.
    Spain, L.
    Azad, A. A.
    Kwan, E.
    Muthusamy, A.
    Torres, J.
    Parente, P.
    Francis, P.
    Parnis, F. X.
    Goh, J.
    Gibbs, P.
    Tran, B.
    Anton, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S1329 - S1330
  • [30] Circulating tumor cell (CTC) enumeration in patients with metastatic neuroendocrine prostate cancer (NEPC) and castration-resistant prostate cancer (CRPC)
    Kaur, Gurveen
    Singh, Beerinder
    Beltran, Himisha
    Akhtar, Naveed Hassan
    Nanus, David M.
    Tagawa, Scott T.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
12345